Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Emactuzumab by SynOx Therapeutics for Tenosynovial Giant Cell Tumor: Likelihood of Approval
Emactuzumab is under clinical development by SynOx Therapeutics and currently in Phase III for Tenosynovial Giant Cell Tumor. According to...